MedTrace Logo

A Pilot Study of Bupivacaine Infusion in Abdominal Surgery

NCT00280553 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-05-15

No results posted yet for this study

Summary

The incisions used in abdominal surgery can be quite painful, requiring strong pain medications. A new pain pump that trickles small amounts of local freezing into the incision has been developed that helps numb the area so that the patient does not feel the pain for two to five days after surgery.

The main research question is whether use of the pain pump will result in decreased hospital length of stay. The research is important because if the pain pump is found to be effective, it can substantially decrease the length of stay. Areas to be studied include hospital length of stay, patient's comfort post-operatively, and post-operative complications.

Conditions

  • Laparoscopic Surgical Procedures

Interventions

DRUG

bupivicaine

PCA and bupivicaine infusion for up to five days

OTHER

Saline infusion

PCA and pump with saline infusion for up to five days

Sponsors & Collaborators

  • McMaster University

    collaborator OTHER

  • The Physicians' Services Incorporated Foundation

    collaborator OTHER

  • St. Joseph's Healthcare Hamilton

    collaborator OTHER

  • Margherita CADDEDU

    lead OTHER

Principal Investigators

  • Margherita Cadeddu, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00280553 on ClinicalTrials.gov